Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios

B. Kirshon, Giancarlo Mari, K. J. Moise, N. Wasserstrum

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Ten pregnancies with 13 fetuses complicated by symptomatic polyhydramnios were treated with indomethacin. A baseline fetal echocardiogram was obtained before therapy, repeated 24 hours after the initiation of indomethacin and then performed weekly provided that the ductus arteriosus remained patent. The mean duration of indomethacin therapy was 28.3 ± 18.9 days. The starting dose in all patients was 25 mg orally every six hours. The ductus arteriosus was noted to constrict in four patients, with the development of tricuspid regurgitation in one. One of the constrictions occurred after 23 days of therapy. In one patient with constriction a reduction of the indomethacin dosage was not associated with constriction, while in the other three, constriction was still evident at a reduced dosage. All constrictions and the tricuspid regurgitation resolved in utero within 24 hours after discontinuation of the indomethacin. We recommend careful monitoring of the fetal ductus arteriosus when treating symptomatic polyhydramnios with indomethacin.

Original languageEnglish (US)
Pages (from-to)529-532
Number of pages4
JournalThe Journal of reproductive medicine
Volume35
Issue number5
StatePublished - 1990
Externally publishedYes

Fingerprint

Polyhydramnios
Ductus Arteriosus
Indomethacin
Constriction
Tricuspid Valve Insufficiency
Therapeutics
Fetal Monitoring
Patent Ductus Arteriosus
Fetus
Pregnancy

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios. / Kirshon, B.; Mari, Giancarlo; Moise, K. J.; Wasserstrum, N.

In: The Journal of reproductive medicine, Vol. 35, No. 5, 1990, p. 529-532.

Research output: Contribution to journalArticle

@article{6c4eba5e686648f5beef7d08e1a9f23d,
title = "Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios",
abstract = "Ten pregnancies with 13 fetuses complicated by symptomatic polyhydramnios were treated with indomethacin. A baseline fetal echocardiogram was obtained before therapy, repeated 24 hours after the initiation of indomethacin and then performed weekly provided that the ductus arteriosus remained patent. The mean duration of indomethacin therapy was 28.3 ± 18.9 days. The starting dose in all patients was 25 mg orally every six hours. The ductus arteriosus was noted to constrict in four patients, with the development of tricuspid regurgitation in one. One of the constrictions occurred after 23 days of therapy. In one patient with constriction a reduction of the indomethacin dosage was not associated with constriction, while in the other three, constriction was still evident at a reduced dosage. All constrictions and the tricuspid regurgitation resolved in utero within 24 hours after discontinuation of the indomethacin. We recommend careful monitoring of the fetal ductus arteriosus when treating symptomatic polyhydramnios with indomethacin.",
author = "B. Kirshon and Giancarlo Mari and Moise, {K. J.} and N. Wasserstrum",
year = "1990",
language = "English (US)",
volume = "35",
pages = "529--532",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "5",

}

TY - JOUR

T1 - Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios

AU - Kirshon, B.

AU - Mari, Giancarlo

AU - Moise, K. J.

AU - Wasserstrum, N.

PY - 1990

Y1 - 1990

N2 - Ten pregnancies with 13 fetuses complicated by symptomatic polyhydramnios were treated with indomethacin. A baseline fetal echocardiogram was obtained before therapy, repeated 24 hours after the initiation of indomethacin and then performed weekly provided that the ductus arteriosus remained patent. The mean duration of indomethacin therapy was 28.3 ± 18.9 days. The starting dose in all patients was 25 mg orally every six hours. The ductus arteriosus was noted to constrict in four patients, with the development of tricuspid regurgitation in one. One of the constrictions occurred after 23 days of therapy. In one patient with constriction a reduction of the indomethacin dosage was not associated with constriction, while in the other three, constriction was still evident at a reduced dosage. All constrictions and the tricuspid regurgitation resolved in utero within 24 hours after discontinuation of the indomethacin. We recommend careful monitoring of the fetal ductus arteriosus when treating symptomatic polyhydramnios with indomethacin.

AB - Ten pregnancies with 13 fetuses complicated by symptomatic polyhydramnios were treated with indomethacin. A baseline fetal echocardiogram was obtained before therapy, repeated 24 hours after the initiation of indomethacin and then performed weekly provided that the ductus arteriosus remained patent. The mean duration of indomethacin therapy was 28.3 ± 18.9 days. The starting dose in all patients was 25 mg orally every six hours. The ductus arteriosus was noted to constrict in four patients, with the development of tricuspid regurgitation in one. One of the constrictions occurred after 23 days of therapy. In one patient with constriction a reduction of the indomethacin dosage was not associated with constriction, while in the other three, constriction was still evident at a reduced dosage. All constrictions and the tricuspid regurgitation resolved in utero within 24 hours after discontinuation of the indomethacin. We recommend careful monitoring of the fetal ductus arteriosus when treating symptomatic polyhydramnios with indomethacin.

UR - http://www.scopus.com/inward/record.url?scp=0025330259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025330259&partnerID=8YFLogxK

M3 - Article

C2 - 2191133

AN - SCOPUS:0025330259

VL - 35

SP - 529

EP - 532

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 5

ER -